Literature DB >> 31819012

Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse.

Paola Merino1, Ariel Diaz1, Enrique R Torre1, Manuel Yepes2.   

Abstract

Growth-associated protein 43 (GAP-43) plays a central role in the formation of presynaptic terminals, synaptic plasticity, and axonal growth and regeneration. During development, GAP-43 is found in axonal extensions of most neurons. In contrast, in the mature brain, its expression is restricted to a few presynaptic terminals and scattered axonal growth cones. Urokinase-type plasminogen activator (uPA) is a serine proteinase that, upon binding to its receptor (uPAR), catalyzes the conversion of plasminogen into plasmin and activates signaling pathways that promote cell migration, proliferation, and survival. In the developing brain, uPA induces neuritogenesis and neuronal migration. In contrast, the expression and function of uPA in the mature brain are poorly understood. However, recent evidence reveals that different forms of injury induce release of uPA and expression of uPAR in neurons and that uPA/uPAR binding triggers axonal growth and synapse formation. Here we show that binding of uPA to uPAR induces not only the mobilization of GAP-43 from the axonal shaft to the presynaptic terminal but also its activation in the axonal bouton by PKC-induced calcium-dependent phosphorylation at Ser-41 (pGAP-43). We found that this effect requires open presynaptic N-methyl-d-aspartate receptors but not plasmin generation. Furthermore, our work reveals that, following its activation by uPA/uPAR binding, pGAP-43 colocalizes with presynaptic vesicles and triggers their mobilization to the synaptic release site. Together, these data reveal a novel role of uPA as an activator of the synaptic vesicle cycle in cerebral cortical neurons via its ability to induce presynaptic recruitment and activation of GAP-43.

Entities:  

Keywords:  GAP-43; plasmin; plasminogen; protease; synapse; urokinase receptor

Mesh:

Substances:

Year:  2019        PMID: 31819012      PMCID: PMC6956544          DOI: 10.1074/jbc.RA119.010644

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19.

Authors:  Nina Irwin; Steven Chao; Luda Goritchenko; Atsuko Horiuchi; Paul Greengard; Angus C Nairn; Larry I Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

2.  The neuronal growth-associated protein GAP-43 interacts with rabaptin-5 and participates in endocytosis.

Authors:  R L Neve; R Coopersmith; D L McPhie; C Santeufemio; K G Pratt; C J Murphy; S D Lynn
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

3.  NMDA receptor blockade prevents kainate induction of protein F1/GAP-43 mRNA in hippocampal granule cells and subsequent mossy fiber sprouting in the rat.

Authors:  R K McNamara; A Routtenberg
Journal:  Brain Res Mol Brain Res       Date:  1995-10

4.  Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.

Authors:  Ekaterina Semina; Kseniya Rubina; Veronika Sysoeva; Karina Rysenkova; Polina Klimovich; Olga Plekhanova; Vsevolod Tkachuk
Journal:  Eur J Cell Biol       Date:  2016-06-03       Impact factor: 4.492

5.  Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons.

Authors:  Fang Wu; Enrique Torre; David Cuellar-Giraldo; Lihong Cheng; Hong Yi; Edyta K Bichler; Paul S García; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

6.  Ultrastructural double localization of B-50/GAP43 and synaptophysin (p38) in the neonatal and adult rat hippocampus.

Authors:  M Van Lookeren Campagne; A B Oestreicher; P M Van Bergen en Henegouwen; W H Gispen
Journal:  J Neurocytol       Date:  1990-12

7.  Neuron-specific protein F1/GAP-43 shows substrate specificity for the beta subtype of protein kinase C.

Authors:  F S Sheu; R M Marais; P J Parker; N G Bazan; A Routtenberg
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

8.  Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice.

Authors:  L Aigner; S Arber; J P Kapfhammer; T Laux; C Schneider; F Botteri; H R Brenner; P Caroni
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582

9.  The expression of growth-associated protein GAP-43 mRNA in the rat hippocampus in response to adrenalectomy and aging.

Authors:  H M Chao; R L Spencer; R R Sakai; B S McEwen
Journal:  Mol Cell Neurosci       Date:  1992-12       Impact factor: 4.314

10.  Structural basis for the interaction of unstructured neuron specific substrates neuromodulin and neurogranin with Calmodulin.

Authors:  Veerendra Kumar; Vishnu Priyanka Reddy Chichili; Ling Zhong; Xuhua Tang; Adrian Velazquez-Campoy; Fwu-Shan Sheu; J Seetharaman; Nashaat Z Gerges; J Sivaraman
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  3 in total

1.  Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.

Authors:  Ariel Diaz; Paola Merino; Patrick McCann; Manuel A Yepes; Laura G Quiceno; Enrique Torre; Amelia Tomkins; Xiaodong Zhang; Chadwick M Hales; Frank C Tong; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

2.  Phosphorylation of GAP-43 T172 is a molecular marker of growing axons in a wide range of mammals including primates.

Authors:  Masayasu Okada; Yosuke Kawagoe; Yuta Sato; Motohiro Nozumi; Yuya Ishikawa; Atsushi Tamada; Hiroyuki Yamazaki; Yuko Sekino; Yonehiro Kanemura; Yohei Shinmyo; Hiroshi Kawasaki; Naoko Kaneko; Kazunobu Sawamoto; Yukihiko Fujii; Michihiro Igarashi
Journal:  Mol Brain       Date:  2021-04-08       Impact factor: 4.041

Review 3.  Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review.

Authors:  Yue Liu; Guang Yang; Wenqiang Cui; Yunling Zhang; Xiao Liang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.